Although several years have passed since health savings accounts became available to Americans, the number of enrollees has remained relatively low. This article explores some of the pitfalls of the plans and the reluctance of the public to climb aboard.
You are here
P&T® Journal contents for May 2007
P&T Around the world
The authors present an update to an earlier P&T article on the embargo of Priorix measles–mumps–rubella vaccine after a deadly health scare in Ho Chi Minh City.
Considerations Associated with Therapeutic Interchange within the Fluoroquinolone Class of Antimicrobials
The author discusses the procedures, safeguards, and costs involved when less expensive agents replace preferred drugs in the same pharmacological class.
The authors describe the changes in the prescribing patterns for NSAIDs that resulted when valdecoxib (Bextra) and rofecoxib (Vioxx) were withdrawn from the market.
Author: Robert L. Shook
Sitagliptin/metformin (Janumet) for diabetes, lapatinib (Tykerb) for HER-2–positive breast cancer, and protein C concentrate powder (Ceprotin) for venous disorders are reviewed.